Aptar Pharma, a leading provider of drug delivery systems, is nearing completion on its expansion at its Congers, NY state-of-the-art manufacturing site. The new space will enable the company to better serve North American pharmaceutical customers, as injectable elastomeric component manufacturing will be completed in the United States for the first time by Aptar.
Final construction is planned by the end of the first quarter of 2017 so that Aptar Pharma can anticipate shipping validation batches to customers in the second quarter of next year. The expansion is part of a stepped program to increase Aptar Pharma’s footprint in the U.S., according to Bas Van Buijtenen, president of the injectables division of Aptar Pharma.
Exclusive Insights: Gain access to in-depth insights and best practices for trends, solutions and innovations for consumer packaged goods processors responsible for food, beverage, household, medical and pharmaceutical packaging.
Comprehensive Coverage: Stay informed with the latest news and trends through our videos, podcasts, eNewsletters, webinars, continuing education resources, and a monthly eMagazine.
Networking Opportunities: Connect with other industry professionals and leaders through our webinars and online platforms.
